Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer | Zendy

Kenneth Rolston | Zendy; Mark Messer | Zendy; D H Ho | Zendy

Open Access

Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer

Author(s) -

Kenneth Rolston,

Mark Messer,

D H Ho

Publication year - 1990

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.34.9.1812

Subject(s) - pseudomonas , microbiology and biotechnology , pseudomonas fluorescens , xanthomonas , pseudomonas aeruginosa , biology , stenotrophomonas maltophilia , pseudomonadaceae , pseudomonas putida , pseudomonadales , quinolone , antimicrobial , antibiotics , bacteria , genetics

The in vitro susceptibilities of three Pseudomonas species (Pseudomonas aeruginosa, Pseudomonas putida, and Pseudomonas fluorescens) and Xanthomonas maltophilia to quinolone antimicrobial agents were determined. Several newer agents, particularly PD117558, PD117596, PD127391, sparfloxacin (AT-4140), A-56620, and temafloxacin, were active against Pseudomonas species. X. maltophilia isolates were generally less susceptible than were Pseudomonas isolates but were inhibited by some of the newer quinolones.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research